COMMUNIQUÉS West-GlobeNewswire
-
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
04/08/2026 -
RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th
04/08/2026 -
Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
04/08/2026 -
Carbonium Core Reports Rare Earth and Critical Mineral Content in Initial Sample Assay
04/08/2026 -
Beacon Behavioral Partners Expands National Footprint with First Georgia Partnership
04/08/2026 -
Zelluna ASA: Disclosure of large shareholding
04/08/2026 -
Dr. Naved Fatmi Expands Leadership in Healthcare, Education, and Community Service with Appointment to Palm Beach State College Foundation Board
04/08/2026 -
Zelluna ASA: Issuance of shares to Inven2 through set-off of settlement amounts under option and license agreement
04/08/2026 -
EmblemHealth and NewYork-Presbyterian Reach New Agreement
04/08/2026 -
Betterbrand Highlights Surging Interest in Mullein as Consumers Turn to Natural Respiratory Wellness Solutions
04/08/2026 -
Flyte Partners with Volato AI to Become First Enterprise Customer, Accelerating Technology Strategy to Scale Regional Private Aviation
04/08/2026 -
United Rentals and the Graham and Courtney Rahal Foundation Raise $125,000 for SoldierStrong at Annual Drivers Tournament
04/08/2026 -
U.S. Oral Surgery Management Names Jennifer Ellis CFO
04/08/2026 -
Novo Nordisk A/S - share repurchase programme
04/08/2026 -
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
04/08/2026 -
Good Salt Life Expands Clean Republic Multipurpose Disinfectant Label with Hospital-Disinfectant Kill Claims, Opening the Door to Healthcare and Animal Care Markets
04/08/2026 -
Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy
04/08/2026 -
ABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib
04/08/2026 -
Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet
04/08/2026
Pages